Trust Board papers November 2012 - Barking Havering and ...
Trust Board papers November 2012 - Barking Havering and ...
Trust Board papers November 2012 - Barking Havering and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Patient Safety <strong>and</strong> Quality<br />
July Aug Sept Target red July Aug Sept Target red July Aug Sept Target Red<br />
Reducing hospital mortality<br />
SHMI ‐ quarterly December 11 95.96<br />
93.92 95.00 % untreated waiting less than 18 weeks 92.70% 92.10% 92.60% 92% 87% LOS (Elective) 3.15 3.31 3.01 3.1 3.48<br />
% emergency admitted patients review by<br />
senior clinician within 12 hours ND ND ND 95% 94% RTT admitted in 18 weeks 91.20% 90.50% 90.40% 90% 85% LOS (Non‐Elective) 5.13 5.02 5.22 4.454 5.05<br />
% emergency admitted patients review by<br />
consultant within 12 hours ND ND ND 95% 94% RTT non‐admitted in 18 weeks 99.50% 98.90% 98.50% 95% 90% LOS (Elective‐ excluding 0 LOS) 3.62 3.78 3.53 3.5 3.92<br />
Maternal Death Rate per 100000 ( rolling 12<br />
m) 32.36 21.66 21.73 TBA TBA RTT not delivered in all specialties 9 6 7 0 >20 LOS (Non‐ Elective‐excluding 0 LOS) 6.36 6.27 6.41 5.8 6.53<br />
% Day case rate ‐ All 88% 90% 88% 80% 75%<br />
Serious Untoward Incidents<br />
Cancer<br />
DTOC 4.69 5.54 4.18 3.50% 5.00%<br />
Number 13 23 18 18 19 2 Wk. % seen all urgent refs & ref for breast* 98.8% 95.3% 94.4% 93% 88% admissions on day of surgery 86.04 94.44 93.83 85% 80%<br />
% reported within 48Hours ‐ quarterly 64%<br />
50% 49% 2 Wk. GP RefTo 1st OP for susp cancer* 99.5% 99.5% 98.4% 93% 88% % patients discharged between 6 am <strong>and</strong> 11 am 11% 13.18% 11.12% 50% 30%<br />
2 Wk GP Ref To 1st OP for breast symptoms* 94.3% 98.9% 97.9% 93% 88%<br />
Infection Control<br />
31 Day 2nd Or Subs Treatment ‐ Surgery* 100.0% 100.0% 100.0% 94% 89%<br />
Enhanced Recovery<br />
MRSA Bacteraemia 6 YTD<br />
6 7 31 Day 2nd Or Subs Treatment ‐ Drug* 100.0% 100.0% 100.0% 98% 93%<br />
% patients with an ERP code entered onto the national<br />
database* 86% 74% 99% 95% 95%<br />
C Diff Infection 37YTD<br />
59 60 31 Day DTT for all cancers* 97.5% 100.0% 99.5% 96% 91% % planned colorectal having GDFT* 57% 78% 37% 80% 80%<br />
MRSA Elective Screening 78% 79% 84% 95% 86% 62 Day RTT From Cancer Screening** 100.0% 90.9% 100.0% 90% 85% % emergency abdominal patients having GDFT* 33% 33% 57% 80% 80%<br />
MRSA Emergency Screening 77% 75% 79% 95% 86% 62 Days ‐ treated from referral ** 88.5% 84.1% 91.4% 86% 80% *one month in arrears * JUNE , JULY <strong>and</strong> AUG data reported<br />
62 Day RTT From Hosp Specialist** 100.0% 100.0% 77.8% 85% 80%<br />
Outpatients<br />
Complaints<br />
62 Days Urgent RTT of all cancers** 88.2% 82.0% 91.5% 85% 80% FFU Ratio 2.13 2.08 2.06 2.16 2.20<br />
% complaints responded to in line with<br />
agreement with patients 87.00% 86.00% 95.00% 80% 79% 31 Day Subs Treatment ‐ Radiotherapy* 100.0% 100.0% 100.0% 94% 89% DNA First 9.83% 9.42% 10.12% 5.00% 5.50%<br />
number of complaints not yet responded to<br />
over 3 months old 18 42 53 TBA TBA * fully validated data provided one month in arrears ** JUNE , JULY <strong>and</strong> AUG data reported DNA Follow‐Up 10.58% 10.58% 10.84% 5.00% 5.50%<br />
Dementia<br />
% patients aged over 75% having a mental<br />
test score 55% 60% 78% 50% 49%<br />
Performance<br />
Referral to Treatment<br />
A&E<br />
Productivity<br />
Four‐Hour Maximum Wait In A&E 92.26% 94.59% 89.37% 95% 94%<br />
Finance<br />
Percentage of patients referred to speciality team<br />